Özet

Background: This study aims to evaluate the long-term results of angiography in patients undergoing off-pump coronary artery bypass grafting (CABG).

Methods: Between September 1993 and December 1995, a total of 162 patients who underwent off-pump CABG by the same two surgeons at a single center, followed by angiography were retrospectively analyzed.

Results: The mean time from surgery to angiography was 9.8±1.2 years (range, 7.1 to 12.6 years). The overall patency rate of the left internal mammary artery graft was 95.57% and 46.03% in saphenous vein grafts (SVG). During follow-up, 27 patients (16.67%) underwent percutaneous coronary intervention. The procedure was performed due to severe stenosis in the SVG in eight of them and due to severe lesion formation in native coronary artery in the others. Five patients underwent repeated CABG. There was no significant association between pre-, intra-, and postoperative variables and graft patency.

Conclusion: Off-pump CABG technique, in contrast to the conventional bypass, has well-known advantages such as lower transfusion of blood and blood products, shortened length of intensive care unit and hospital stay, reduced cost, and lower morbidity and mortality. Our very long-term angiographic follow-up study showed that off-pump CABG is as reliable as conventional bypass procedure with excellent outcome and patency particularly in the left anterior descending coronary artery. Therefore, off-pump CABG technique should be the primary procedure of choice in selected patients.

Coronary artery bypass grafting (CABG) surgery is a reliable treatment for coronary artery disease with reproducible results. However, the results of CABG, both with and without cardiopulmonary bypass (CPB), are still being debated.[1-4] Extracorporeal circulation and aortic cross-clamping can cause deleterious effects, such as the activation of immunological cascades, microembolization, and macroembolization, resulting in neurological, renal, and gastrointestinal dysfunction along with global myocardial ischemia/ reperfusion injury (RI).[1] Off-pump coronary artery bypass (OPCAB) has been proposed to avoid these negative effects since it reduces the risks of postoperative morbidity, length of intensive care unit (ICU) and hospital stays, and the cost of the coronary revascularization procedure.[2-4] Because the OPCAB technique requires distal anastomosis to be performed on the beating heart, there are concerns that the long-term patency of the grafts may well be adversely affected.[1,2,5,6] The purpose of this study was to evaluate the very long-term angiographic results of OPCAB operations performed over a 10-year period at a single center.

Yöntem

Five hundred and fifty-one patients who were operated by the same two surgeons between September 1993 and December 1995 at the Koşuyolu Heart and Research Hospital were evaluated in this study via preoperative and operative data that was collected from the hospital database and patient records. Each patient was contacted by telephone, and those who were eligible were invited for a control examination. In addition, informed consent was obtained from each of the patients. We were able to reach 182 patients from the telephone and address records, but we could not contact 369 others due to changes in the telephone numbers and addresses or because of incomplete records. Furthermore, 20 patients who were alive during the follow-up period of this study did not give their consent since they had had no indication of the need for cardiac catheterization since their operation. In the end, 162 patients (134 males, 28 females; mean age 53.3±9.9 years) who had control cardiac catheterizations during the follow-up period were included in the final analysis for very longterm angiographic and clinical assessments of the outcomes.

The OPCAB was performed with elastic silicone loops placed around the coronary arteries which were proximal and distal to the anastomotic site of the artery. No intracoronary shunt was used during these procedures, and only the proximal portion of the artery was occluded by a snare or bulldog clamp to achieve a bloodless field for anastomosis. The distal segment was never occluded, and further improved visualization was achieved by blowing air during the anastomosis. When a saphenous vein graft (SVG) was used, first the distal and then the proximal anastomosis was completed. Before initiating the procedure, heparin was administered to keep the activated clotting time (ACT) at between 200-250 seconds. A beta (b)-blocker was also used to keep the heart rate below 80 beats/minute. Since there was no apparent drainage, the heparin was not neutralized with protamine sulfate.

All data is presented as mean ± standard deviation (SD) or as an interquartile range. Chi-square and Fisher’s exact tests were used to compare categorical variables, and the Mann-Whitney U test was used to compare continuous variables. To predict the relationship between the postoperative graft occlusion and various risk factors, a logistic regression analysis was performed, and a p value of <0.05 was considered to be statistically significant.

Bulgular

All of the study participants underwent a control angiography during the follow-up period, and the mean follow-up time from the time of the operation to this procedure was 9.8±1.2 years (range 7.1-12.6 years). The preoperative risk factors and associated conditions are listed in Table 1.

Table 1: Preoperative variables

The operative data is shown in Table 2. The left internal mammary artery (LIMA) was used as the conduit of choice for the left anterior descending artery (LAD) in 158 (97.53%) of the patients while the right internal mammary artery (RIMA) was used for the right coronary artery (RCA) bypass grafting in two patients and for the LAD in one. The great SVG was used in the remaining anastomoses. One hundred and eighteen patients (72.84%) were completely revascularized, and two (1.23%) underwent an endarterectomy to the RCA.

Table 2: Operative variables

The peri- and postoperative morbidities are listed in Table 3. Perioperative myocardial infarction (MI) was detected in eight of the patients (4.94%). One of these had occluded LIMA and SVG grafts in the control angiography, and three had a patent LIMA but occluded SVG grafts. The grafts were patent in the remaining four patients.

Table 3: Peri- and postoperative variables

Very long-term cardiac mortality occurred at a rate of 4.8% in three patients. One patient with chronic renal failure was lost due to acute MI following dialysis nine years after the original surgery, another died because of decompensated congestive heart failure during the postoperative ninth, and the third patient was reoperated on because of graft occlusion in the ninth year of follow-up and did not survive the surgery.

The LIMA graft was patent in 151 patients (95.57%) while two of the RIMA grafts were in this same condition (66.67%). In addition, one of the RIMA grafts on which RCA was performed was occluded. We also determined that the patency of the SVG was lower (46.03%), and we observed superior patency of the bypass grafts when they were performed on the LAD (Table 4).

Table 4: The patency of the bypass grafts in relation to the target vessels We also divided the patients into three groups according whether there was patency in all, some, or none of the bypassed grafts. In addition, we examined the effects of the preoperative and postoperative variables (Table 5) and found no significant differences between these groups with regard to any of the preoperative variables. However, postoperative atrial fibrillation was significantly higher in the patients with non-patent grafts (p=0.0001), and the length of hospital stay was also significantly longer in those patients (p=0.043). The logistic regression analysis determined that none of the variables were associated with graft occlusion.

Table 5: An analysis of the pre- and postoperative variables within the patency groups

Percutaneous coronary intervention (PCI) was necessary in 27 patients (16.67%) during the follow-up period, and eight of these had significant stenosis in the SVG (4.94%). The remaining subjects had a new onset of significant lesions in the native coronary arteries. Furthermore, one patient with occluded LIMA and SVG grafts and four with LIMA occlusion underwent reoperations.

Tartışma

Avoiding the morbidities associated with CPB, for example aortic cannulation and clamping, hypothermia, cardiac arrest, systemic hemodilution, and impaired hemostasis, has become possible via the introduction of the OPCAB procedure. It is well known that this technique is associated with less systemic inflammation, reduced transfusion requirements, the preservation of renal function, better myocardial function, and reduced atrial fibrillation as well as a decrease in pulmonary dysfunction, reduced costs, and less mortality.[1,7-9] Despite the aforementioned advantages, only 15-20% of the CABG operations are conducted using the OPCAB technique.[2,7,10,11]

A recent report by Filardo et al.,[12] which compared the long-term survival between off-pump and on-pump CABG patients (over 12 years of follow-up) stated that the OPCAB group was at an increased risk of death (18%) independent of their preoperative severity. Additionally, the authors suggested that the might have caused this difference. In multivessel disease, on-pump CABG is frequently the technique of choice, but for patients needing less bypass vessels, OPCAB is still sometimes preferred to achieve the goal of complete revascularization. In our patient group, complete revascularization was achieved in 118 (72.84%) of the patients and long-term cardiac mortality was seen in 4.8%. In the mortality group, complete revascularization occurred in 66.67% of the patients while in 27.16%, it was incomplete. However, there was no association between the late outcome (angina recurrence, MI, or death) and incomplete revascularization.

The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial showed that the statin therapy used to achieve LDL levels of less than 100 mg/dL was independently associated with improved graft patency.[13] Omeroglu et al. investigated the mid-term angiographic results of OPCAB at our institution, and they also stated that graft type and hyperlipidemia were significant risk factors for graft occlusion.[5] In contrast to these findings, neither hyperlipidemia nor statin therapy had any effect on graft patency in our patients. Furthermore, there were some variables other than hyperlipidemia that were quite different between the patients with patent anastomoses and those with occluded anastomoses (e.g., diabetes). However, because of the small sample size in our study, it is likely that these differences were not statistically significant.

The primary concern regarding the use of OPCAB has been the patency of the bypassed grafts due to the technically challenging requirement for the anastomoses to be performed on a beating heart. In our study, the LIMA patency was 95.57% but the SVG patency was lower at 46.03%. In long-term follow-up studies, the LIMA and SVG patencies of on-pump CABG patients were between 80 and 94% and 45 and 75%, respectively.[14-18] The main limitation of this study was its retrospective design and small sample size. In addition, we lacked a second comparison group with on-pump CABG patients because there were no digital patient records at that time; therefore, establishing a propensity-matched group was not possible. Despite these limitations, our study was able to provide the very long-term angiographic results of OPCABG operations, and even though there was a very long follow-up period in our study, the patencies of the LIMA-LAD and LAD-targeted grafts (95.57% and 100%) were still comparable to the findings of short- and mid-term control studies.[5,19-23]

Sonuçlar

No definitive conclusions regarding can be drawn from previously mentioned large clinical trials and studies regarding the superiority of either strategy or selection criteria of patients on the outcomes of on-pump and off-pump CABG since no randomized, doubleblinded, prospectively designed trial is available.[24] This technique may be technically challenging, but it offers superior patient comfort along with reduced costs and less morbidity. The superior very long-term patency rates of the LIMA-LAD grafts and LADtargeted grafts in our patient group should garner special attention since the hybrid revascularization procedures are becoming more popular.[25,26] In this study, the angiographic controls revealed the superior patency of the LAD-targeted grafts (95.57-100%) over a time period of up to 10 years. In suitable patients, the handling of coronary arteries other than the LAD with PCI while performing an LAD bypass with OPCAB may prove to be a good alternative procedure that can provide favorable outcomes.

Declaration of conflicting interests
The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.

Funding
The authors received no financial support for the research and/or authorship of this article.

Kaynaklar

1) Raja SG, Dreyfus GD. Current status of off-pump coronary artery bypass surgery. Asian Cardiovasc Thorac Ann 2008;16:164-78.

2) Angelini GD, Culliford L, Smith DK, Hamilton MC, Murphy GJ, Ascione R, et al. Effects of on- and off-pump coronary artery surgery on graft patency, survival, and healthrelated quality of life: long-term follow-up of 2 randomized controlled trials. J Thorac Cardiovasc Surg 2009;137:295-303.

3) Cheng DC, Bainbridge D, Martin JE, Novick RJ; Evidence- Based Perioperative Clinical Outcomes Research Group. Does off-pump coronary artery bypass reduce mortality, morbidity, and resource utilization when compared with conventional coronary artery bypass? A meta-analysis of randomized trials. Anesthesiology 2005;102:188-203.

4) Wijeysundera DN, Beattie WS, Djaiani G, Rao V, Borger MA, Karkouti K, et al. Off-pump coronary artery surgery for reducing mortality and morbidity: meta-analysis of randomized and observational studies. J Am Coll Cardiol 2005;46:872-82.

5) Omeroğlu SN, Kirali K, Güler M, Toker ME, Ipek G, Işik O, Yakut C. Midterm angiographic assessment of coronary artery bypass grafting without cardiopulmonary bypass. Ann Thorac Surg 2000;70:844-9.

6) Kim KB, Lim C, Lee C, Chae IH, Oh BH, Lee MM, Park YB. Off-pump coronary artery bypass may decrease the patency of saphenous vein grafts. Ann Thorac Surg 2001;72:S1033-7.

7) Puskas JD, Williams WH, O'Donnell R, Patterson RE, Sigman SR, Smith AS, et al. Off-pump and on-pump coronary artery bypass grafting are associated with similar graft patency, myocardial ischemia, and freedom from reintervention: long-term follow-up of a randomized trial. Ann Thorac Surg 2011;91:1836-42.

8) Reston JT, Tregear SJ, Turkelson CM. Meta-analysis of shortterm and mid-term outcomes following off-pump coronary artery bypass grafting. Ann Thorac Surg 2003;76:1510-5.

9) Puskas JD, Kilgo PD, Lattouf OM, Thourani VH, Cooper WA, Vassiliades TA, et al. Off-pump coronary bypass provides reduced mortality and morbidity and equivalent 10-year survival. Ann Thorac Surg 2008;86:1139-46.

10) Edelman JJ, Yan TD, Padang R, Bannon PG, Vallely MP. Offpump coronary artery bypass surgery versus percutaneous coronary intervention: a meta-analysis of randomized and nonrandomized studies. Ann Thorac Surg 2010;90:1384-90.

11) Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009;360:961-72.

12) Filardo G, Grayburn PA, Hamilton C, Hebeler RF Jr, Cooksey WB, Hamman B. Comparing long-term survival between patients undergoing off-pump and on-pump coronary artery bypass graft operations. Ann Thorac Surg 2011;92:571-7.

13) Kulik A, Voisine P, Mathieu P, Masters RG, Mesana TG, Le May MR, Ruel M. Statin therapy and saphenous vein graft disease after coronary bypass surgery: analysis from the CASCADE randomized trial. Ann Thorac Surg 2011;92:1284-90.

14) Fitzgibbon GM, Kafka HP, Leach AJ, Keon WJ, Hooper GD, Burton JR. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol 1996;28:616-26.

15) Mack MJ, Osborne JA, Shennib H. Arterial graft patency in coronary artery bypass grafting: what do we really know? Ann Thorac Surg 1998;66:1055-9.

16) Loop FD. Coronary artery surgery: the end of the beginning. Eur J Cardiothorac Surg 1998;14:554-71.

17) Lytle BW, Loop FD, Cosgrove DM, Ratliff NB, Easley K, Taylor PC. Long-term (5 to 12 years) serial studies of internal mammary artery and saphenous vein coronary bypass grafts. J Thorac Cardiovasc Surg 1985;89:248-58.

18) Goldman S, Copeland J, Moritz T, Henderson W, Zadina K, Ovitt T, et al. Long-term graft patency (3 years) after coronary artery surgery. Effects of aspirin: results of a VA Cooperative study. Circulation 1994;89:1138-43.

19) Khan NE, De Souza A, Mister R, Flather M, Clague J, Davies S, et al. A randomized comparison of off-pump and on-pump multivessel coronary-artery bypass surgery. N Engl J Med 2004;350:21-8.

20) Lingaas PS, Hol PK, Lundblad R, Rein KA, Tønnesen TI, Svennevig JL, et al. Clinical and Angiographic Outcome of Coronary Surgery with and without Cardiopulmonary Bypass: A Prospective Randomized Trial. Heart Surg Forum 2004;7:37-41.

21) Nathoe HM, van Dijk D, Jansen EW, Suyker WJ, Diephuis JC, van Boven WJ, et al. A comparison of on-pump and offpump coronary bypass surgery in low-risk patients. N Engl J Med 2003;348:394-402.

22) Lamy A, Devereaux PJ, Prabhakaran D, Taggart DP, Hu S, Paolasso E, et al. Off-pump or on-pump coronary-artery bypass grafting at 30 days. N Engl J Med 2012;366:1489-97.

23) Lamy A, Devereaux PJ, Prabhakaran D, Taggart DP, Hu S, Paolasso E, et al. Effects of off-pump and on-pump coronaryartery bypass grafting at 1 year. N Engl J Med 2013;368:1179-88.

24) Sellke FW, DiMaio JM, Caplan LR, Ferguson TB, Gardner TJ, Hiratzka LF, et al. Comparing on-pump and off-pump coronary artery bypass grafting: numerous studies but few conclusions: a scientific statement from the American Heart Association council on cardiovascular surgery and anesthesia in collaboration with the interdisciplinary working group on quality of care and outcomes research. Circulation 2005;111:2858-64.

25) Repossini A, Tespili M, Saino A, Kotelnikov I, Moggi A, Di Bacco L, et al. Hybrid revascularization in multivessel coronary artery disease. Eur J Cardiothorac Surg 2013;44:288-93.

26) Green KD, Lynch DR Jr, Chen TP, Zhao D. Combining PCI and CABG: the role of hybrid revascularization. Curr Cardiol Rep 2013;15:351.